Burden of diabetes in Australia: life expectancy and disability-free life expectancy in adults with diabetes

Abstract

Aims/hypothesis The aim of this work was to estimate the life expectancy (LE) and disability-free life expectancy (DFLE) for adults with and without diabetes. Methods The Chiang method and the adapted Sullivan method were used to estimate LE and DFLE by age and sex. Mortality data in 2011 were available from the National Diabetes Services Scheme for diabetes and from standard national mortality datasets for the general population. Data on prevalence of disability and severe or profound core activity limitation were derived from the 2012 Australian Survey of Disability, Ageing and Carers (SDAC). The definitions of disability used in the SDAC followed the International Classification of Functioning, Disability and Health. Data on diabetes prevalence were derived from the Australian Diabetes, Obesity and Lifestyle study. ResultsThe estimated LE and DFLE (with 95% uncertainty interval [UI]) at age 50 years were 30.2 (30.0, 30.4) and 12.7 (11.5, 13.7) years, respectively, for men with diabetes, and the estimates were 33.9 (33.6, 34.1) and 13.1 (12.3, 13.9) years, respectively, for women with diabetes. The estimated loss of LE associated with diabetes at age 50 years was 3.2 (3.0, 3.4) years for men and 3.1 (2.9, 3.4) years for women, as compared with their counterparts without diabetes. The corresponding estimated loss of DFLE was 8.2 (6.7, 9.7) years for men and 9.1 (7.9, 10.4) years for women. Women with diabetes spent a greater number of absolute years and a greater proportion of their life with disability as compared with men with diabetes and women without diabetes. The gains in LE and DFLE across the whole population at age 50 years after hypothetically eliminating diagnosed diabetes were 0.6 (0.5, 0.6) years and 1.8 (1.0, 2.8) years. Conclusions/interpretation In adults, diabetes results in a modest reduction in LE and a substantial reduction in DFLE. Efforts to identify the specific causes of disability and effective interventions are needed.

The Productivity Burden of Diabetes at a Population Level

“…We also show that the relative impact of diabetes on years of life lost was slightly greater among men. This was because the prevalence of diabetes was generally higher among men, and they did not live as long as women (12). In a burden of disease study, Begg et al (13).…”

Age 80 years and over is not associated with increased morbidity and mortality following pancreaticoduodenectomy

“…A reduction in the survival in older patients may also relate to age‐related predicted lower life expectancy in those aged 80 years and older. The general population's life expectancy in Australia is trending up and men and women aged 80 or over are expected to live for another 10 years, while the life expectancy in people aged 65 is double that of those 80 years and over . Nevertheless, given the life expectancy of up to 10 or more years in the octogenarian or older population, consideration for surgery appears a valid option in highly selected patients operated on by experienced surgeons in tertiary hospitals.…”

A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study

“…The cardiovascular morbidity associated with type 2 diabetes poses a major health issue for individuals as well as an economic burden on the healthcare system. Individuals with type 2 diabetes have a life expectancy that is reduced by around 5 years and a disability-free life expectancy reduced by up to 9 years [2, 3]. …”